Arch Capital Group (NASDAQ:ACGL) was upgraded by analysts at Deutsche Bank AG from a hold rating to a buy rating.
argenx (NASDAQ:ARGX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company’s product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands. “
ARMOUR Residential REIT (NYSE:ARR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “ARMOUR Residential REIT, Inc. invests primarily in residential mortgage-backed securities issued or guaranteed by a United States Government-chartered entity. “
AdvanSix (NYSE:ASIX) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “AdvanSix Inc. is a producer and supplier of Nylon 6 materials. The company’s polymer resin sold under the Aegis(R) brand to produce engineered plastics, fibers, filaments and films which in turn used in end products such as automotive and electronic components, carpets, sports apparel, fishing nets and food as well as industrial packaging. AdvanSix also produces caprolactam, the main feedstock for producing nylon; Caprannylon film(R); Sulf-N (R) ammonium sulfate fertilizers and chemical intermediates, including phenol, acetone, and Nadone (R) cyclohexanone. AdvanSix Inc. is based in Morris Plains, United States. “
AtriCure (NASDAQ:ATRC) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. “
AVIVA PLC/ADR (OTCMKTS:AVVIY) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Aviva has established a competitive position in North America. In the US, the world’s largest savings market, Aviva is the leading provider of indexed annuity and indexed life insurance products. Its principal activity is the provision of financial products and services, focused on the following lines of business: long-term insurance and savings business, fund management and general insurance and health. The company’s business is managed on a geographic basis through a regional management structure based on four regions, U.K., Europe, North America and Asia Pacific. The four regions function as five operating segments as, due to the size of the U.K. region, it is split into two operating segments, U.K. Life and U.K. General Insurance, which undertake long term insurance and savings business and general insurance respectively. “
Natus Medical (NASDAQ:BABY) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. “
Banco Bilbao Vizcaya Argentaria (NYSE:BBVA) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Banco Bilbao Vizcaya is engaged in a wide variety of banking, financial and related activities in Spain. “
BioTelemetry (NASDAQ:BEAT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “BioTelemetry, Inc. provides ambulatory outpatient management solutions for monitoring clinical information regarding an individual’s health. It is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. BioTelemetry, Inc., formerly known as CardioNet, Inc., is headquartered in Conshohocken, Pennsylvania. “
DiamondRock Hospitality (NYSE:DRH) was upgraded by analysts at Wells Fargo & Co from an underperform rating to a market perform rating.
Micron Technology (NASDAQ:MU) was given a $50.00 target price by analysts at Royal Bank of Canada. The firm currently has a buy rating on the stock.
Sunstone Hotel Investors (NYSE:SHO) was upgraded by analysts at Wedbush from a neutral rating to an outperform rating.
Schneider Electric (EPA:SU) was given a €80.00 ($93.02) price target by analysts at JPMorgan Chase & Co.. The firm currently has a buy rating on the stock.
W. R. Berkley (NYSE:WRB) was downgraded by analysts at Deutsche Bank AG from a hold rating to a sell rating.
Receive News & Ratings for Arch Capital Group Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Capital Group Ltd and related companies with MarketBeat.com's FREE daily email newsletter.